Nucleotide polymorphism associated with ethambutol resistance in clinical isolates of Mycobacterium tuberculosis

Current Microbiology

Volumn 53, Issue 5, 2006, Pages 401-405

  Srivastava, S ^a   Garg, A ^a   Ayyagari, A ^a   Nyati, K K ^a   Dhole, T N ^a   Dwivedi, S K ^b  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^b BABASAHEB BHIMRAO AMBEDKAR UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL PROTEIN; ETHAMBUTOL; NUCLEOTIDE; PROTEIN EMBB; PROTEIN EMBC; UNCLASSIFIED DRUG;

ADULT; ANIMAL CELL; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; CLINICAL ARTICLE; CODON; CONTROLLED STUDY; DNA POLYMORPHISM; GENE ISOLATION; GENE MUTATION; HUMAN; LUNG TUBERCULOSIS; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS;

ANTITUBERCULAR AGENTS; DRUG RESISTANCE, BACTERIAL; ETHAMBUTOL; HUMANS; MICROBIAL SENSITIVITY TESTS; MUTATION; MYCOBACTERIUM TUBERCULOSIS; POLYMORPHISM, GENETIC;

HUMAN IMMUNODEFICIENCY VIRUS; MYCOBACTERIUM TUBERCULOSIS;

EID: 33750562550     PISSN: 03438651     EISSN: 14320991     Source Type: Journal    
DOI: 10.1007/s00284-006-0135-1     Document Type: Article

References (30)

1. Blessington B, Beiraghi A (1990) Study of the stereochemistry of ethambutol using chiral liquid chromatography and synthesis. J Chromatogr 522:195-203
2. Wilkinson RG, Sheperd RG, Thomas JP, Baughn C (1961) Stereospecificity of a new type of synthetic antituberculosis agent. J Am Chem Soc 83:2212-2213
3. Alcaide F, Pfyffer GE, Telenti A (1997) Role of embB in natural and acquired resistance to ethambutol in mycobacteria. Antimicrob Agents Chemother 41:2270-2273
4. Belanger AE, Besra GS, Ford ME, Mikusová KI, Belisle JT, Brennan PJ, et al. (1996) The embAB genes of Mycobacterium avium encode an arabinosyl transferase involved in cell wall arabinan biosynthesis that is the target for the antimycobacterial drug ethambutol. Proc Natl Acad Sci USA 93:11919-11924
5. Maddry JA, Suling WJ, Reynolds RC (1996) Glycosyltransferases as targets for inhibition of cell wall synthesis in M. tuberculosis and M. avium. Res Microbiol 147:106-112
6. Mikusová K, Slayden RA, Besra GS, Brennan PJ (1995) Biogenesis of the mycobacterial cell wall and the site of action of ethambutol. Antimicrob Agents Chemother 39:2484-2489
7. Besra GS, Khoo KH, McNeil MR, Dell A, Morris HR, Brennan PJ (1995) A new interpretation of the structure of the mycolylarabinogalactan complex of Mycobacterium tuberculosis as revealed through characterization of oligoglycosylalditol fragments by fast-atom bombardment, mass spectrometry, and 1H nuclear magnetic resonance spectroscopy. Biochemistry 34:4257-4266
8. Brennan PJ, Nikaido H (1995) The envelope of mycobacteria. Annu Rev Biochem 64:39-63
9. Khoo KH, Douglas E, Azadi P, Inamine JM, Besra GS, Mikusová K, et al. (1996) Truncated structural variants of lipoarabinomannan in ethambutol drug-resistant strains of Mycobacterium smegmatis. Inhibition of arabinan biosynthesis by ethambutol. J Biol Chem 271:28682-28690
10. Takayama K, Armstrong EL, Kunugi KA, Kilburn JO (1979) Inhibition by ethambutol of mycolic acid transfer into the cell wall of Mycobacterium smegmatis. Antimicrob Agents Chemother 16:240-242
11. Takayama K, Kilburn JO (1989) Inhibition of synthesis of arabinogalactan by ethambutol in Mycobacterium smegmatis. Antimicrob Agents Chemother 33:1493-1499
12. Musser JM (1995) Antimicrobial agent resistance in mycobacteria: Molecular genetic insights. Clin Microbiol Rev 8:496-514
13. Sander P, Bottger EC (1999) Mycobacteria: Genetics of resistance and implications for treatment. Chemotherapy 45:95-108
14. Telenti A, Philipp WJ, Sreevatsan S, Bernasconi C, Stockbauer KE, Wieles B, et al. (1997) The emb operon, a gene cluster of Mycobacterium tuberculosis involved in resistance to ethambutol. Nat Med 3:567-570
15. Escalante P, Ramaswamy S, Sanabria H, Soini H, Pan X, Valiente Castillo O, et al. (1998) Genotypic characterization of drug-resistant Mycobacterium tuberculosis isolates from Peru. Tuberc Lung Dis 79:111-118
16. Lee HY, Myoung HJ, Bang HE, Bai GH, Kim SJ, Kim JD, et al. (2002) Mutations in the embB locus among Korean clinical isolates of Mycobacterium tuberculosis resistant to ethambutol. Yonsei Med J 43:59-64
17. Ramaswamy SV, Amin AG, Goksel S, Stager CE, Dou SJ, El Sahly H, et al. (2000) Molecular genetic analysis of nucleotide polymorphisms associated with ethambutol resistance in human isolates of Mycobacterium tuberculosis. Antimicrob Agents Chemother 44:326-336
18. Ramaswamy SV, Dou SJ, Rendon A, Yang Z, Cave MD, Graviss EA (2004) Genotypic analysis of multidrug-resistant Mycobacterium tuberculosis isolates from Monterrey, Mexico. J Med Microbiol 53:107-113
19. Sreevatsan S, Stockbauer KE, Pan X, Kreiswirth BN, Moghazeh SL, Jacobs WR Jr, et al. (1997) Ethambutol resistance in Mycobacterium tuberculosis: Critical role of embB mutations. Antimicrob Agents Chemother 41:1677-1681
20. Van Rie A, Warren R, Mshanga I, Jordaan AM, van der Spuy GD, Richardson M, et al. (2001) Analysis for a limited number of gene codons can predict drug resistance of Mycobacterium tuberculosis in a high-incidence community. J Clin Microbiol 39:636-641
21. Chadha VK (2005) Tuberculosis epidemiology in India: A review. Int J Tuberc Lung Dis 9:1072-1082
22. WHO Global Tuberculosis Control-WHO Report (2002) Geneva, Switzerland. WHO/CDS/TB/2002
23. Manual of Laboratory Methods (1987) Tuberculosis Research Centre, Chennai, India
24. van Soolingen D, Hermans PW, de Haas PE, Soll DR, van Embden JD (1991) Occurrence and stability of insertion sequences in Mycobacterium tuberculosis complex strains: Evaluation of an insertion sequence-dependent DNA polymorphism as a tool in epidemiology of tuberculosis. J Clin Microbiol 29:2578-2586
25. Masur H (1993) Recommendation on prophylaxis and therapy for disseminated M. avium complex disease inpatients infected with HIV virus. N Engl J Med 329:828-833
26. Deng L, Milkusová K, Robuck KG, Scherman M, Brennan PJ, McNeil MR (1995) Recognition of multiple effects of ethambutol on metabolism of mycobacterial cell envelope. Antimicrob Agents Chemother 39:694-701
27. Forbes M, Kuck NA, Peets EA (1965) Effect of ethambutol on nucleic acid metabolism in Mycobacterium smegmatis and its reversal by polyamines and divalent cations. J Bacteriol 89:1299-1305
28. Kilburn JO, Takayama K, Armstrong EL, Greenberg J (1981) Effects of ethambutol on phospholipid metabolism in Mycobacterium smegmatis. Antimicrob Agents Chemother 19:346-348
29. Wolucka BA, McNeil MR, de Hoffmann E, Chojnacki T, Brennan PJ (1994) Recognition of the lipid intermediate for arabinogalactan/arabinomannan biosynthesis and its relation to the mode of action of ethambutol on mycobacteria. J Biol Chem 269:23328-23335
30. Mokrousov I, Otten T, Vyshevskiy , Narvskaya O (2002) Detection of emb306 mutations in ethambutol-susceptible clinical isolates of Mycobacterium tuberculosis from Northwest Russia: Implications for genotypic resistance testing. J Clin Microbiol 40:3810-3813